GRIFOLS | GRF - Ebitda

Stock Price
8.95
Daily Change
0 0%
Monthly
-0.11%
Yearly
5.12%
Q2 Forecast
8.72

GRIFOLS reported EUR347.24M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Alcon AG USD 317M 337M Dec/2025
Almirall EUR 114.07M 60.37M Dec/2025
Amadeus IT EUR 577.9M 74.8M Dec/2025
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 387.05M 99.02M Sep/2025
AstraZeneca USD 5.23B 272M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Cie Automotive EUR 345.96M 35.96M Dec/2024
Demant DKK 2.76B 165M Dec/2025
Ence Energia y Celulosa EUR 12.8M 100K Dec/2025
Essilor EUR 3.09B 356M Dec/2024
Ferrovial EUR 542M 607M Dec/2025
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
Galapagos EUR 2.42M 161.13M Sep/2025
Genmab DKK 186M 291M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Inditex EUR 2.97B 223M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 4.77B 1.11B Dec/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.6B 570M Dec/2025
Viscofan EUR 63.38M 8.37M Mar/2026